SCHEMBL7526213

SCHEMBL7526213

COCCNC(=O)C(N)c1cccc(C(=O)c2ccc(F)cc2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA4 P22748 6/20 0.46
CA12 O43570 5/20 0.46
CA2 P00918 5/20 0.46
CA9 Q16790 5/20 0.46
CA1 P00915 4/20 0.46
LMNA P02545 1/20 0.44
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
GLI1 P08151 1/20 0.42
GLI2 P10070 1/20 0.42
HPGD P15428 2/20 0.41
NPC1 O15118 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
DGAT2 Q96PD7 1/20 0.38
CTSL P07711 2/20 0.38
CTSK P43235 1/20 0.38
SLC6A9 P48067 1/20 0.38
SLC6A5 Q9Y345 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5575264 0.77 HPGD (0.51) HPGDSMN1; SMN2
SCHEMBL3729801 0.76 HPGD (0.61) HPGDSMN1; SMN2
SCHEMBL11462125 0.75 SMN1; SMN2 (0.53) LMNAPTGS1PTGS2HPGDSMN1; SMN2
SCHEMBL93570 0.75 CTSL (0.48) LMNAPTGS1PTGS2HPGDSMN1; SMN2
Water SCHEMBL11470792 0.72 SMN1; SMN2 (0.46) CA2CA1LMNAPTGS1PTGS2
SCHEMBL32679738 0.70 HPGD (0.66) HPGDNPC1RAB9ASMN1; SMN2
SCHEMBL11223070 0.70 MAPT (0.56) CA4CA12CA2CA9CA1
SCHEMBL11461547 0.70 PTGS1 (0.71) CA4CA12CA2CA9CA1
SCHEMBL11480826 0.70 HPGD (0.46) LMNAHPGDNPC1RAB9ASMN1; SMN2
SCHEMBL20646759 0.69 TP53BP1 (0.64) HPGDSMN1; SMN2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0716600-B1 TOPICALLY ADMINISTRABLE COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISORDERS ALCON LAB INC (US) 2002-04-03 EP claimed
EP-0716600-A1 TOPICALLY ADMINISTRABLE COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISORDERS ALCON LABORATORIES, INC. (US) 1996-06-19 EP claimed
WO-1995033457-A1 TOPICALLY ADMINISTRABLE COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISORDERS ALCON LABORATORIES, INC. (US) 1995-12-14 WO claimed
US-5475034-A Adminstering 3-benzoylphenylacetamide derivatives ALCON LABORATORIES, INC. (US) 1995-12-12 US claimed
EP-0716600-B1 TOPICALLY ADMINISTRABLE COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISORDERS ALCON LAB INC (US) 2002-04-03 EP disclosed
EP-0716600-A1 TOPICALLY ADMINISTRABLE COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISORDERS ALCON LABORATORIES, INC. (US) 1996-06-19 EP disclosed
WO-1995033457-A1 TOPICALLY ADMINISTRABLE COMPOSITIONS CONTAINING 3-BENZOYLPHENYLACETIC ACID DERIVATIVES FOR TREATMENT OF OPHTHALMIC INFLAMMATORY DISORDERS ALCON LABORATORIES, INC. (US) 1995-12-14 WO disclosed
US-5475034-A Adminstering 3-benzoylphenylacetamide derivatives ALCON LABORATORIES, INC. (US) 1995-12-12 US disclosed